Arbor Biotechnologies IPO

Arbor Biotechnologies uses AI and machine learning to develop gene editing therapeutics that aim to treat genomic diseases. Their current pipeline focuses on liver and Central Nervous System (CNS) diseases. Arbor Biotechnologies was founded in 2016 by David Scott Ph.D., Winston Yan Ph.D., David Walt Ph.D., and Feng Zhang Ph.D. and is headquartered in Cambridge, MA.

Register for Details

For more details on financing and valuation for Arbor Biotechnologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Arbor Biotechnologies

Forge green plus iconForge green minus icon

What is Arbor Biotechnologies's IPO price?

The IPO price for Arbor Biotechnologies will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Arbor Biotechnologies?

Arbor Biotechnologies is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Arbor Biotechnologies shares pre-IPO?

If you own Arbor Biotechnologies pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Arbor Biotechnologies a publicly traded company?

Arbor Biotechnologies is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Arbor Biotechnologies's funding to date?

Arbor Biotechnologies has raised $231.6MM to date.
Forge green plus iconForge green minus icon

When was Arbor Biotechnologies founded?

Arbor Biotechnologies was founded in 2016.

Who are Arbor Biotechnologies's major investors?

Tao Capital Partners
Arch Venture Partners
GreatPoint Ventures
Section 32
TCG Crossover Management
Ridgeback Capital

Arbor Biotechnologies Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
11/9/2021 Series B $215MM raised $XXX.XX $XXX.XX
5/19/2017 Series A $16.6MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 26, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.